GENERAL COMMENTS
Thank you for the opportunity to review this very interesting manuscript. Introduction
The study is based on guideline-based or guideline-appropriate hospital performance measure. Guideline-recommended hospital performance measure does not seem to be the right word, as the guideline does not recommend the performance measure. The introduction does not clarify if the performance measure is stroke specific. Overall the Introduction is very basic and does not give insight into the current literature in this field. There is only limited information on the scientific background Method Section The data, the study is based on is described clearly. The performance measures consist of six core measures und three guideline-recommended secondary prevention metrics. Here it would be nice to know, which performance measure belongs to the core measures. Please state why 20 people as the minimum denominator has been chosen. This information can be found twice (page 11, line 54). The methodological approach with regard to the RSM Rate is being described very precisely. The RSM is based on the multi-level approach, considering the different case-mix within the hospitals.
Results Table 3 : it must be IV rt-Pa < 2 hours not IV rt-PA for 2 hours, as well as on page 8 line 19 and page 13 line 27. Unfortunately the RSM rates are being described within in the method section, but not in the results. As this is are interesting results there should be some information within the results. What is the ICC of the multilevel model? How much variance between the hospitals can be explained by the organizational level? This would be very interesting to know.
To only look at the correlation between the performance measures und between the RSM and the performance measure is only a very basic approach. As there are more data available on the hospital level a multivariable approach would give further insight into the study topic. As mentioned in the limitations it would be possible to have a closer look at possible confounders, like number of treated stroke patients, hospital size or location.
Discussion
The Discussion begins with the statement, that ischemic stroke care is suboptimal in China. Here further information would be necessary why the authors come to this conclusion. The discussion is very basic and does not go into detail, when it comes to interpretation of the findings. Current findings like a prolonged time frame to perform thrombolysis is not mentioned.
Professional proof-reading is being advised. However the main issue with the manuscript is that ten year old data are being used to make inferences about modern day care. Whilst I commend the work put in by the authors to investigate an important topic I believe that without the inclusion of more recent data the conclusions which can be taken and applied are limited.
REVIEWER
VERSION 1 -AUTHOR RESPONSE Reviewer #1 Comments:
(1) Pearson correlation coefficients is a parametric test, which takes for granted normal distributions of variables. Therefore its use is not properly justified in the statistical analysis section. Did you perform any tests to confirm normality of distributions like Kolmogorov-Smirnov or Shapiro-Wilk test or any other? If not please explain why. If there are problems with normality of variables then you should consider using non-parametric tests like Spearman rank correlation method for your statistical analysis. This is extremely important as it may influence the accuracy of your results! Response: Thank you for your constructive suggestions. After the Shapiro-Wilk test, we found our data was in skewed distribution. Thus, we re-analyzed the data using the Spearman rank correlation. The main results and the conclusion were not significantly affected. (Line 2-4 in Page 13, Page 19) The Response: Thank you for your constructive comments. We calculated "% variance explained" by using the coefficient of determination. We have stated the detailed information of coefficient of determination in the Methods section (Line 5-8 in Page 13): We reported both the relevant correlation coefficients and the percentage of the hospital performance measures in risk standardized mortality rates explained, ie, the square of the correlation coefficient, as indicators of the strength of the associations.
As the correlation coefficients have been changed by using the Spearman rank correlation as mentioned above, we have modified the corresponding values in Table 5 Response: Thank you for your constructive comments. In our study, the first acute performance measure was that intravenous tissue-type plasminogen activator (tPA) in patients who arrive within 2 hours after symptom onset and treated within 3 hours. We excluded the patients who received thrombolysis within 3-4.5 hours. The reason was as follows. Although the guidelines of acute stroke in the American Heart Association/American Stroke Association (AHA/ASA) and the European Stroke Organisation (ESO) have expanded the time window of intravenous thrombolysis to 4.5 hours, the guideline of acute ischemic stroke in China did not expand this time window until 2014 (I, B). (Chin J Neurol 2015; 48:246-257 .) When our study carried out, the Chinese guideline of acute ischemic stroke just recommended intravenous thrombolysis within 3 hours. Thus, our study did not included the patients received thrombolysis within 3-4.5 hours. As the guideline having updated in China as well, we will include and analyze the patients who received thrombolysis within 3-4.5 hours in the future study. We also added this information in the limitation section. 3. Reviewer #2 Comments:
(1) Introduction: The study is based on guideline-based or guideline-appropriate hospital performance measure. Guideline-recommended hospital performance measure does not seem to be the right word, as the guideline does not recommend the performance measure. The introduction does not clarify if the performance measure is stroke specific. Overall the Introduction is very basic and does not give insight into the current literature in this field. There is only limited information on the scientific background.
Response: Thank you for your constructive comments. As you advised, we have modified the phrase of "guideline-recommended hospital performance measures" to "evidence-based hospital performance measures" in our manuscript. The relevant contents in the manuscript have also been modified. We have also expanded the introdution section to better clarify the background literature, research question and significance of this study. (Line 2-15 in Page 6) In addition, we also clarified that the hospital performance measures was stroke specific to quantify and promote the quality of care for stroke and TIA patients in the introduciton section. (Line 5-7 in Page 6) (2) Method Section: The data, the study is based on is described clearly. The performance measures consist of six core measures und three guideline-recommended secondary prevention metrics. Here it would be nice to know, which performance measure belongs to the core measures. Please state why 20 people as the minimum denominator has been chosen. This information can be found twice (page 11, line 54). The methodological approach with regard to the RSM Rate is being described very precisely. The RSM is based on the multi-level approach, considering the different case-mix within the hospitals.
Response: Thank you for your constructive comments. Firstly, after confirmation, we found the core measures were actually seven. We have modified the relevant contents in the manucript and clarified which performance measure belongs to the core measures in the Methods section: We evaluated nine hospital performance measures, including seven "core" measures for acute ischemic stroke as recommended by American Heart Association/American Stroke Association (AHA/ASA) Get With The Guidelines-Stroke (GWTG-Stroke) (Circ Cardiovasc Qual Outcomes 2010;3:291-302.) and two additional evidence-based secondary prevention metrics (CNS Neurosci Ther 2012;18:93-101.). These seven core performance measures included (1) intravenous tissue-type plasminogen activator (tPA) in patients who arrive within 2 hours after symptom onset and treated within 3 hours (IV rt-PA < 2 Hour), (2) antithrombotic medication within 48 hours of admission (early antithrombotics), (3) deep vein thrombosis (DVT) prophylaxis within 48 hours of admission for nonambulatory patients (DVT prophylaxis), (4) antithrombotic medication, (5) anticoagulation for atrial fibrillation (AF) , (6) medications for lowering low-density lipoprotein (LDL) ≥100 mg/dL, (7) smoking cessation. The two additional performance measures were antihypertensive medication for patients with hypertension and hypoglycemia medication for diabetes mellitus. (Line 10-21 in Page 8) Secondly, as the hospitals with less patients might lead to bias of the analyses of our study, we excluded hospitals with fewer than 20 patients, which value was considered as generally accepted, in the denominator of a measure to define a threshold for stable site-level performance assessment.
(3) Results: Table 3 : it must be IV rt-Pa < 2 hours not IV rt-PA for 2 hours, as well as on page 8 line 19 and page 13 line 27. Unfortunately the RSM rates are being described within in the method section, but not in the results. As this is are interesting results there should be some information within the results. What is the ICC of the multilevel model? How much variance between the hospitals can be explained by the organizational level? This would be very interesting to know. To only look at the correlation between the performance measures und between the RSM and the performance measure is only a very basic approach. As there are more data available on the hospital level a multivariable approach would give further insight into the study topic. As mentioned in the limitations it would be possible to have a closer look at possible confounders, like number of treated stroke patients, hospital size or location.
Response: Thank you for your constructive suggestions. Firstly, we have modified "IV rt-PA for 2 hours" to "IV rt-Pa < 2 hours" in the manuscript. Secondly, As you advised, besides the median (interquartile range), we further analyzed more information about the RSM rates. We calculated the inter-class correlation (ICC) of 30-day and 1-year RSM rates. The ICC of 30-day RSM rate was 0.065, and the ICC of 1-year RSM rate was 0.041, which reflects low homogeneity of patients in each hospital. We added this information in the results section. (Line 11-12 in Page 19) Thirdly, you advised us to build a multivariable approach on hospital level to give the further insight into the study topic. However, the model we used in our study was the Centers for Medicare and medicaid Services (CMS) model, which considered the intercepts between hospitals as random variables, but not included other data on hospital levels into analyses. ["Statistical Issues in Assessing Hospital Performance" (2012). Quantitative Health Sciences Publications and Presentations. 1114. https://escholarship.umassmed.edu/qhs_pp/1114] The CMS, through a subcontract with Yale New Haven Health Services Corporation, Center for Outcomes Research and Evaluation(YNHHSC/CORE), is supporting a committee appointed by the Committee of Presidents of Statistical Societies(COPSS) to address statistica lissues identified by the CMS and stakeholders about CMS's approach to modeling hospital quality based on outcomes. The CMS model believed that all hospital-level influences on outcome would take care of themselves in that the unadjusted standard mortality rates would accurately capture them. Indeed, the hospital effects would consolidate the effects of all hospital-level factors and in this"very large information"context would be equivalent to estimating a separate intercept for each hospital. Furthermore, the CMS model believed the case that hospital-level attributes from category, such as volume for different procedures, locations, ownership and management, teaching status, should not be used when computing expected mortality when "rolling up" thepatient-specific probabilities in the national model that is used to produce the denominator for the RSM rates. Thus, we did not include the multivariable approach on the hospital level in our study.
(4) Discussion: The Discussion begins with the statement, that ischemic stroke care is suboptimal in China. Here further information would be necessary why the authors come to this conclusion. The discussion is very basic and does not go into detail, when it comes to interpretation of the findings. Current findings like a prolonged time frame to perform thrombolysis is not mentioned.
Response: Thank you for your constructive comments. Firstly, we came to this conclusion that ischemic stroke care was suboptimal in China when we compared our data with the Get With The Guidelines-Stroke (GWTG-Stroke) in America. The GWTG-Stroke was the successful tools of improving the national quality of stroke care in America. The comparison showed that many hospital performance measures in China were far down from the GWTG-Stroke (Circulation 2009; 119:107-15. Stroke 2016; 47:2843-49.) Secondly, current findings like the prolonged time frame to perform thrombolysis was not mentioned in our study. The reason was as follows. Although the guidelines of acute stroke in the American Heart Association/American Stroke Association (AHA/ASA) and the European Stroke Organisation (ESO) have expanded the time window of intravenous thrombolysis to 4.5 hours, the guideline of acute stroke in China did not expand this time window until 2014 (I, B). (Chin J Neurol 2015; 48:246-257 .) When our study carried out, the Chinese guideline of acute ischemic stroke just recommended intravenous thrombolysis within 3 hours. Thus, our study did not included the patients received thrombolysis within 3-4.5 hours. As the guideline updated in China as well, we will include and analyze the patients who received thrombolysis within 3-4.5 hours in the future study. We also added this information in the limitation section. (Line 16-19 in Page 26) (5) Professional proof-reading is being advised.
Response: Thank you for your suggestion. The language has been polished by a native English professor.
Reviewer #3 Comments:
Obviously, the study data have two levels: the first (lowest) level is patients' level (n= 14,526 patients), and the second (higher) level is hospital level (n=132 hospitals), usually we would say "the patients were nested by different hospitals". The use of Pearson correlation coefficient for such two-level data was obviously wrong!! They should use linear mixed model or hierarchical linear model, to treat hospital performance data as the second level variable and the treat patients' responding as the first level variable, and see the coefficient of the second level variable or the variance explained by the second level variable.
Response: Thank you for your constructive comments. As you mentioned, we have two levels in our data: the patients' level and the hospitals' level. In fact, when calculating the stroke outcomes, the risk-standardized mortality (RSM) rates, we have already used a multivariate hierarchical regression model, which included these two levels (the patients' level and the hospitals' level). The first level of the hierarchical model included patient characteristics (demographics and clinical features, vascular risk factors, and other pre-existing comorbid condition). The second level included hospital-specific random intercepts that allow for different baseline mortality rates between hospitals, as previouly reported. Thus, when we analyzed the correlations between performance measures and RSM rates, we did not use the hierarchical linear model again.
Reviewer #4 Comments:
Thank you for your manuscript investigating hospital performance measures and actual outcome data. From a statistical point of view the manuscript is sound. Really correction for multiple comparisons should be performed such as the bonferroni correction. Bonferroni is a simple alteration to the alpha value which can be easily applied. It is overly conservative leading to type II errors so there are other, more complex, options which would be equally valid. However the main issue with the manuscript is that ten year old data are being used to make inferences about modern day care. Whilst I commend the work put in by the authors to investigate an important topic I believe that without the inclusion of more recent data the conclusions which can be taken and applied are limited.
Response: Thank you for your constructive comments. Firstly, as you advised, we performed the bonferroni correction in the multiple comparisons. (Line 4-5 in Page 13) The 
GENERAL COMMENTS
I believe that authors answered adequately to the comments and remarks that were adressed to them and that the manuscript is now complete and correct VERSION 2 -AUTHOR RESPONSE Reviewer #2 Comments:
(1) Intrduction: 1.9 Million deaths caused by stroke are mentioned here. In what time frame, per year?
Response: Thank you for your constructive suggestions. According to the cause-specific mortality for 240 causes in China, stroke was responsible for around 1.9 million deaths in 2013 in China (Lancet 2016; 387:251-72.) . We have modified the sentence in the Introduction section. (Line 2-3 in Page 6) (2) Please state within the introduction how the research question can be answered with data this old. This is essential as new trends in the treatment of stroke (extension of the time frame to perform thrombolysis) have not been considered. This should be more clearly adressed not only within the limitations. Although China did not change its guidelines until 2014, positive outcome have been proven for an extended time frame.
Response: Thank you for your constructive comments. As you advised, we further discussed the relationship between our research question and the data we used in the Introduction section. "The China National Stroke Registry (CNSR) was a national hospital-based, prospective stroke registry, which encompassed different regions and had good representativeness. CNSR thoroughly investigated all indicators related to the quality of stroke care, including evidence-based acute performance measures and performance measures at discharge. Thus, it could reflect the real situation of stroke care in China." (Line 16-20 in Page 6) (3) Within the results first the correlations with the 1 year RSM rate are being mentioned, followed by the correlations with the 30 day RSM. This should be turned around, as it is doubtful if the 1 year RSM rates can still be attributed to the acute hospital stay. The more important result, that there is no correlation between the performance measure and the 30 day RSM should be mentioned first.
Response: Thank you for your constructive comments. As you advised, we have adjusted the order in the Result section. (Line 13-14 and 20-22 in Page 19) The relevant contents in the manuscript have also been modified.
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